相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Application of molecular technologies for phosphoproteomic analysis of clinical samples
M. Pierobon et al.
ONCOGENE (2015)
Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis
Sonia A. Melo et al.
CANCER CELL (2014)
Clinical Utility of a Plasma-Based miRNA Signature Classifier Within Computed Tomography Lung Cancer Screening: A Correlative MILD Trial Study
Gabriella Sozzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Systems Analysis of the NCI-60 Cancer Cell Lines by Alignment of Protein Pathway Activation Modules with -OMIC Data Fields and Therapeutic Response Signatures
Giulia Federici et al.
MOLECULAR CANCER RESEARCH (2013)
miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer
Bi-Lan Li et al.
MEDICAL ONCOLOGY (2013)
Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis
P. Dong et al.
ONCOGENE (2013)
MiR-130b Is a Prognostic Marker and Inhibits Cell Proliferation and Invasion in Pancreatic Cancer through Targeting STAT3
Gang Zhao et al.
PLOS ONE (2013)
Cabozantinib Inhibits Growth of Androgen-Sensitive and Castration-Resistant Prostate Cancer and Affects Bone Remodeling
Holly M. Nguyen et al.
PLOS ONE (2013)
MicroRNA-130b Promotes Tumor Development and Is Associated with Poor Prognosis in Colorectal Cancer
Tommaso Colangelo et al.
NEOPLASIA (2013)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study
Angela M. Liu et al.
BMJ OPEN (2012)
The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials
Andreas Varkaris et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. De Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
One-Step Preservation of Phosphoproteins and Tissue Morphology at Room Temperature for Diagnostic and Research Specimens
Claudius Mueller et al.
PLOS ONE (2011)
MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer
Mattia Boeri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Integrative Genomic Profiling of Human Prostate Cancer
Barry S. Taylor et al.
CANCER CELL (2010)
miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1
Stephanie Ma et al.
CELL STEM CELL (2010)
TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
Xiaohua Su et al.
NATURE (2010)
Watchful waiting and active surveillance: the current position
Jan Adolfsson
BJU INTERNATIONAL (2008)
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities
Desiree Bonci et al.
NATURE MEDICINE (2008)
Androgen receptor is a tumor suppressor and proliferator in prostate cancer
Yuanjie Niu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The androgen receptor negatively regulates the expression of c-Met: Implications for a novel mechanism of prostate cancer progression
Meletios Verras et al.
CANCER RESEARCH (2007)
The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis
Jianhua Wang et al.
CANCER AND METASTASIS REVIEWS (2006)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Inactivation of AR activates HGF/c-Met system in human prostatic carcinoma cells
Akinobu Maeda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Regulation of cancer cell migration and bone metastasis by RANKL
DH Jones et al.
NATURE (2006)
Epithelial-restricted gene profile of primary cultures from human prostate tumors: A molecular approach to predict clinical behavior of prostate cancer
S Nanni et al.
MOLECULAR CANCER RESEARCH (2006)
The RUNX genes: Gain or loss of function in cancer
K Blyth et al.
NATURE REVIEWS CANCER (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy
AV D'Amico et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Androgen receptor mutations in androgen-in dependent prostate cancer: Cancer and Leukemia Group B Study 9663
ME Taplin et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription
K Reisinger et al.
JOURNAL OF CELL SCIENCE (2003)
Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer
P Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Androgen receptor as a target in androgen-independent prostate cancer
SP Balk
UROLOGY (2002)
Androgen receptor phosphorylation - Regulation and identification of the phosphorylation sites.
D Gioeli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Molecular biology of the androgen receptor
EP Gelmann
JOURNAL OF CLINICAL ONCOLOGY (2002)
Structural basis for the glucocorticoid response in a mutant human androgen receptor (ARccr) derived from an androgen-independent prostate cancer
PM Matias et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)
分享论文
